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Abstract
This work establishes the zebrafish embryomodel for ionizing radiation (IR)modifier research and also evaluates the
protective effect of L-alpha glycerylphosphorylcholine (GPC). Embryos were exposed to a single-fraction whole-
body gamma irradiation (5, 10, 15, and 20 Gy) at different postfertilization time points and were serially assessed for
viability and macro- and micromorphologic abnormalities. After toxicity evaluation, 194lMof GPCwas added for
certain groups with 3-h incubation before the radiation. Nuclear factor kappa B (NF-jB) and interleukin-1b (IL-1b)
expression changesweremeasured using quantitative real-timepolymerase chain reaction.Ahigher sensitivity could
be observed at earlier stages of the embryogenesis. The lethal dose (LD50) for 6 hours postfertilization (hpf) embryos
was 15Gy and for 24 hpfwas 20Gy on day7, respectively.GPC administration resulted in a significant improvement
in both the distortion rate and survival of the 24 hpf embryos. Qualitative evaluation of the histological changes
confirmed the protective effect of GPC. IL-1b and NF-jB overexpression due to 10 Gy irradiation was also reduced
byGPC. GPC exhibited promising radioprotective effects in our zebrafish embryomodel, decreasing the irradiation-
induced morphological damage and lethality with significant reduction of IR-caused pro-inflammatory activation.
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Introduction
RADIATION THERAPY IS one of the main pillars of complexcancer management. Radiation biological research has
led to a significant improvement in effective cancer cell
killing and the preservation of normal tissue function, re-
sulting in an improvement in the therapeutic index. Cell
cultures and small mammalian animals are well-established
widely used models for preclinical investigations. In the era
of rapid development of highly selective and combinative
radiation technology, there is a need for a new in vivo model
for studying the effects of different radiation qualities and
radiation modifiers in a complex organism.1
Zebrafish (Danio rerio) embryos have recently been in-
troduced as a novel vertebrate preclinical research model for
various human diseases and treatments as their genome is
remarkably similar to the human genome and they possess
several other advantages.2 The zebrafish model represents
an important step between in vitro cell culture experiments
and small animal studies. These small Asian fishes can be
rapidly bred in large numbers and are easy to maintain at a
relatively low cost in the laboratory. They are vertebrate
organisms, and therefore, complex biological processes can
be investigated. Zebrafish are excellent tools for experi-
mental human cancer research as many key genes involved
in cell cycle, oncogenesis, tumor suppression, and DNA
repair are conserved between the two species.3 Embry-
ogenesis occurs outside of the body and genetic manipu-
lation can be easily performed. Embryo development is
extremely rapid during the first few days postfertilization
while the embryos and larvae are transparent, giving the
possibility to study the in vivo organ development and
perturbations.4 These features, combined with easy han-
dling in experimental conditions, enable the assessment of
ionizing radiation (IR) effects on zebrafish development5
and for studying radiation response modifiers. The combi-
nation strategy, using radiation in conjunction with radia-
tion modifiers, is designed to make the tumor cells more
1Attosecond Light Pulse Source, ELI-HU Nonprofit Ltd., Szeged, Hungary.
2MTA-SE NAP B Cognitive Translational Behavioural Pharmacology Group, Department of Pharmacology and Pharmacotherapy,
Semmelweis University, Budapest, Hungary.
3Institute of Surgical Research, University of Szeged, Szeged, Hungary.
4Department of Oncotherapy, University of Szeged, Szeged, Hungary.
5Institute of Aquaculture and Environmental Safety, Szent Istva´n University of Go¨do¨ll}o, Go¨do¨ll}o, Hungary.
6Department of Pathology and Forensic Veterinary Medicine, Szent Istva´n University, Budapest, Hungary.
ZEBRAFISH
Volume 13, Number 6, 2016
ª Mary Ann Liebert, Inc.
DOI: 10.1089/zeb.2016.1269
481
susceptible to radiation damage and/or to selectively protect
the healthy tissues surrounding the tumor.
Phosphatidylcholine (PC), an essential lipid component of
all kinds of cell membranes and blood proteins, has emerged
as a promising tool for normal cell protection. PC serves
in the central nervous system (CNS) as the main source of
choline, an essential nutrient and precursor to the neuro-
transmitter acetylcholine, and has an enhanced role in mu-
cosal cells, which maintain lung function and gastrointestinal
health.6 GPC (L-alpha glycerylphosphorylcholine) is a water
soluble deacylated PC intermediate, which has been devel-
oped and studied as a potent anti-inflammatory and neuro-
protective agent. Research suggests that GPC positively
enhances the inflammatory response and potentially reduces
the tissue damage caused by IR.7 GPC can be hydrolyzed to
choline and possibly used for the resynthesis of PC.8
Brownawell et al.9 investigated the toxicity of GPC in
rodents by examining the acute, subacute, and late effects of
different GPC doses from 100mg/kg bw to 1000mg/kg bw
in rats. The acute lethal dose of intravenously administered
GPC was 2000mg/kg bw, and the intraperitoneal dosing of
rats produced mortality starting at 1500mg/kg bw, while oral
administration resulted in mortality from 10,000mg/kg bw.
In subchronic or chronic studies and doses of 100 and
300mg/kg bw, GPC did not alter the behavior, body weight,
hematology, or clinical chemistry of rats and did not produce
any signs of general toxicity. In hemorrhagic shock experi-
ments (a prototype of systemic IR), concentrations of GPC
significantly lower than the well tolerated dose caused rats to
recover to baseline levels after 24 h.10
GPC has proved effective against the loss of the membrane
function in CNS injuries11,12 and was previously tested as
a centrally acting parasympathomimetic drug in dementia
disorders and acute cerebrovascular diseases.13–15 GPC, after
oral administration, has been shown to cross the blood–brain
barrier and reach the CNS, where it is incorporated into the
phospholipid fraction of the neuronal plasma membrane and
microsomes.16 GPC was found to inhibit the transfer process
of bifunctional phospholipid transfer protein.17 Furthermore,
GPC has also been proven to protect membranes from oxi-
dation and is able to improve membrane function after trau-
matic damage.12,18
GPC has exhibited protective activity in different experi-
mental models against damage occurring due to inflamma-
tory reaction.19 Experiments of T}oke´s et al.20 and Ghyczy
et al.21 have shown PC to be effective in stopping the pro-
duction of reactive oxygen species both in vitro and in vivo
and may exhibit anti-inflammatory properties.12,18 GPC may
therefore be a possible future candidate for protection of the
normal tissues exposed to incident IR during cancer radio-
therapy. In a rat focal-brain irradiation model, GPC was
proven to alleviate the radiation-induced decline in cognitive
function and to decrease the microscopic brain damage.22,23
The primary aim of the research was to establish the zeb-
rafish (D. rerio) embryo model for radiobiology research
especially for the investigation of the effects of agents, which
may modify (protect or sensitize) the IR. One of the emerging
radioprotectors, the GPC, was tested in this work. Research
performed included detection of survival, morphological, and
histological changes and acute cytokine response. Radiation-
induced damage at the membrane and DNA level can be
modified either using sensitizer or protective agent. In the
case of cancer therapy, both the selective tumor cell sensitizer
and normal tissue radioprotective agent could enhance the
efficacy of radiotherapy (i.e., the therapeutic index could
be improved).
Materials and Methods
The experimental protocol was approved by the Ethics
Committee for the Protection of Animals in Scientific Re-
search at the University of Szeged (XXXII./1838.2015) and
followed the National Institutes of Health (Bethesda, MD)
guidelines on the care and use of laboratory animals.
Embryo harvesting and maintenance
Laboratory-bred strain (AB) of zebrafish (D. rerio) was
purchased from the Department of Aquaculture, Szent Istva´n
University, Go¨do¨ll}o. Adult zebrafish were segregated by sex,
fed twice a day with dry fish food supplemented with freshly
hatched Artemia nauplii, and kept at 27.5C on a 14-h light/
10-h dark cycle. Wild-type adult fish were mated in embryo
collection tanks in the afternoon, and the eggs were spawning
the following morning. Viable embryos were washed and
sorted by microscopic observation (1 embryo/well of standard
96-well polystyrenemicroplates in 250lL embryomedium) at
the one- to two-cell stages and maintained under normoxic
conditions at 27.5C. The embryo medium in each well was
changed at 24, 48, 72, and 120 hours postfertilization (hpf).
Irradiation setup and initial testing
A Teragam K-01 (SKODA UJP) cobalt unit was used
(average energy 1.25 MeV and source isocenter distance
80 cm) to irradiate embryos individually dispensed in 96-well
plates. Irradiation time correction factors were used to
compensate for the decay of the cobalt-60 source.
The plates were placed between two polymethyl methac-
rylate (PMMA) slabs (thickness 2 cm) to compensate for the
built-up effect and to ensure the homogenous radiation expo-
sure. The isocenter was positioned in the plates’ geometrical
centers. Half of the planned dosewere delivered by a 20·20 cm
beam downward (gantry angle 0), while the other half with an
identical beam upward (gantry angle 180) to maximize the
dose homogeneity. This isocentric setup ensured that the dose
uncertainty originating from the movements of the embryos
could be eliminated (Fig. 1). The delivered dose was changed
from5 to 20Gy in 5Gy increments for each group of embryos at
6 hpf and at 24 hpf, respectively, to establish the age-related
dose–response survival curves.
Thereafter, the 24 hpf embryos were selected for studying
the radiation modifier effect at 20 Gy dose level, which proved
to be the LD50. The highest nonlethal dose of 10 Gy was
determined for the subsequent molecular investigations.
Toxicity assessment of GPC
Zebrafish embryos at 24 hpf were exposed to GPC (25mg
dissolved in 1mL single distilled water; Lipoid GmbH). A
toxicity test was conducted using different dilutions in the
absence of radiation. GPC (194.0, 243.0, 324.0, 468.0, 972.0,
and 1944lM/L from 9720 lM/L stock solution) was added to
embryos for 3 h followed by a change in the medium and then
embryos were maintained at 28.5C for 168 h to define sur-
vival and morphological changes.
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Investigations of the effects of radiation
on GPC pretreated embryos
The GPC at 194 lM/L dose level was incubated for 3 h and
the embryos were exposed to 20 Gy at 24 hpf for survival
analysis and to 10 Gy at 24 hpf for molecular examination,
divided into four groups as follows: Control, GPC treated,
irradiated, and GPC treated followed by irradiation.
Morphology and survival analysis
Individual embryo was continually assessed for survival in
each experiment at 24-h intervals from the point of fertil-
ization until 168 hpf. Embryos were observed without any
manipulation in place in the microplates. Viability was ana-
lyzed with light transmission using a Nikon Eclipse TS100
inverted microscope (Nikon Americas, Inc.) at 10 · , 20 ·
magnification and representative images were acquired at
10 ·magnification using a Nikon Coolpix 4500 (4.0 mega
pixels 4· zoom) camera. Survival was calculated as a per-
centage of viable embryos to the total number of embryos
exposed in each treatment group over time. The reported
results represent the mean of at least two replicated experi-
ments. The criterion of embryonic survival was the presence
of cardiac contractility. Similarly, morphology was assessed
visually and photo documented. The size and shape of the
embryo, skull, spine, and tail, the development of the dif-
ferent organs (eye, brain, and midline), yolk sac resorption,
and pericardial edema were evaluated daily in the proportion
of the living embryos.
Histopathology evaluation
For histological assessments, the groups of control and
treated embryos were sacrificed after 7 days of observation,
were placed in 1:100 dilution of 4mg/mL tricaine methane-
sulfonate (Sigma-Aldrich), then fixed by immersion (4%
paraformaldehyde 3 days), and embedded in paraffin. Trans-
verse whole-body sections (4lm thickness) were taken and
stained with hematoxylin and eosin.
Sections were analyzed using a Zeiss Axio Imager Z1 light
microscope (Zeiss EC Plan Neofluar 5 · /0.16, 10· /0.3,
20· /0.5 M27) at 5 · to 20 ·magnification, and photomicro-
graphs were taken using an AxioCam MR5 camera equip-
ment. At least 15 embryos from each treatment group were
observed by two independent investigators.
RNA isolation, reverse transcription,
and quantitative polymerase chain reaction
The inflammatory cytokine level was measured using
three different 20 embryos/treatment group. The total RNA
extraction was isolated by TRIzol (Invitrogen) using a ho-
mogenizer (IKA, T10 digital ULTRA-TURRAX). Chloro-
form (200 lL) was then added to the homogenized embryo
tissue. RNA was precipitated by adding isopropanol (500lL;
Sigma-Aldrich), then the tubes were gently rotated, to ensure
mixing, and then incubated for 10min at room temperature.
After centrifugation (12,000 g, 20min, 4C), the supernatant
was removed and washed in 1mL 75% ethanol (Reanal). The
remaining material was dissolved in 22 lL RNAse-free
water. RNA concentration was measured by the MaestroNano
spectrophotometer. cDNA was synthetized from 1lg total
RNA with random hexamer primers using RevertAid First
Strand cDNA Synthesis Kit (Thermo Scientific) according to
the manufacturer’s instructions. Real-time polymerase chain
reaction (PCR) was performed using a CFX96 Real Time
System (Bio-Rad) to detect changes in mRNA expression,
using 4lL of diluted cDNA template mixed with 1lL of each
primer and 10lL of SYBR Green PCR Master mix (Applied
Biosystems) at a final volume of 20lL with a thermal cycle
(95C 2min) followed by 40 amplification cycles (95C 10 s
then 60C 30 s).
Interleukin-1b (IL-1b) and nuclear factor kappa B (NF-
jB) levels were measured using sequence-specific TaqMan
FIG. 1. The radiation ex-
posure experimental setup.
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gene expression assays (Life Technologies) with 18S rRNA
used a preoptimized primer and probe assay (Applied Bio-
systems) for endogenous control. Each PCR reaction was




All values are reported as standard error of mean (SEM).
For survival curves, Kaplan–Meier analysis was used with
SEM error bars. The averages of two groups were compared
with one-way analysis of variance (ANOVA). Statistical
significance was defined at p< 0.05.
Data assessment of the GPC radioprotection effects is
performed using the Cox regression using the R statistical
program language (R 3.2.2 for Windows).
For inflammatory cytokine measurement evaluation, data
analysis was performed with a commercial statistical soft-
ware package (SigmaStat for Windows; Jandel Scientific).
Nonparametric methods were used, and the differences
between groups were subjected to Kruskal–Wallis one-way
ANOVA on ranks, followed by Dunn’s method for pairwise
multiple comparison. In Figures 6 and 7, median values
(M), 75th percentiles (p75), and 25th percentiles (p25)
are given. p-Values <0.05 were considered significant.
p < 0.05 relative to the control group, #p < 0.05 relative to




Survival. Daily assessment of embryo viability showed a
strong inverse correlation with the radiation dose. During the
7-day observation period, no relevant mortality occurred at
5 Gy for embryos irradiated at 6 hpf, while more than 80%
was already dead at 96 hpf at 20 Gy. From the beginning of
day 4, a significant declination of the survival curve was seen
at 10 and 15 Gy. At day 7, 70% of the embryos were alive in
the 10 Gy group and 50% were alive in the 15 Gy irradiated
group. Therefore, 15 Gy was established as the LD50 for
embryos irradiated at 6 hpf. One hundred percent mortality
occurred with 20 Gy irradiation at 6 hpf by day 5 and most
died with severe morphologic abnormalities (Fig. 2A).
Embryos at 24 hpf were less susceptible to radiation with
20 Gy shown to be LD50 at day 6–7. Lower doses (5–15 Gy)
of irradiation caused no relevant mortality up to day 6. At day
7, 2%–7% of the embryos irradiated <20 Gy died with the
remainder still viable (Fig. 2C).
Morphologic deterioration. Various distortions were de-
tected after delivery of a dose ‡5 Gy, including a reduction in
the body length, spine curvature, microcephaly, micro-
phthalmia, micrognathia, pericardial edema, and the inhi-
bition of yolk sac resorption.
The number of incidence of serious embryonic develop-
mental defects was proportional to the radiation dose and age
FIG. 2. The effects of ionizing radiation on zebrafish development and survival. Zebrafish embryos at 6 or 24 hpf were
exposed to 0, 5, 10, 15, or 20 Gy. (A, C) The proportion of viable to total zebrafish embryos at 6 and 24 hpf. 0 Gy (Control,
A), 5 Gy (,), 10 Gy (C), 15 Gy (D), 20 Gy (B), and survival were determined at 0, 24, 48, 72, 96, 120, 144, and 168 hpf.
Morphology was also daily evaluated in each group (B, D). hpf, hours postfertilization.
484 SZABO´ ET AL.
of the embryos similar to survival; major distortions occurred
earlier if irradiation was performed at 6 hpf. On day 3, more
than 60%–80% of the embryos, which had received 15–20
Gy, showed relevant developmental impairment. On day 4,
the morbidity rate reached 100% at 20 Gy (Fig. 2B).
In contrast, at least 80% of the older embryos (24 hpf) had
developed normally when exposed to IR. Relevant deteriora-
tion occurred during day 4 and increased thereafter at 15–20
Gy (Fig. 2D).
The effects of GPC on survival and distortion. GPC was
added at different concentrations and incubation times to
determine the GPC toxicity and tolerability. Zebrafish em-
bryos at 24 hpf were exposed to increasing concentrations of
GPC for 3–6 h, and the effects on survival and morphological
changes were observed up to 7 days. Relevant toxicity was
observed in the case of longer incubation time (>3 h) result-
ing in 3 h incubation being maintained throughout the study.
The embryos treated with escalated doses of GPC during 3 h
did not show any signs of toxicity; the viability and mor-
phology were not affected.
The pronounced protective effects were detected at each
GPC dose level from 194 to 972lM/L administered before
IR treatment, but there were no perceptible differences be-
tween these concentrations. Both the GPC-treated and con-
trol groups were viable at day 7. Embryos irradiated with 20
Gy without GPC pretreatment started to die at day 3; in
contrast, all embryos exposed to 20 Gy and treated with GPC
were still alive. From day 4, survival decreased in both ir-
radiated groups, but the mortality was more pronounced in
the group without GPC pretreatment. On day 7, the difference
in survival between the GPC pretreated and irradiated group
and the irradiated control group was 20% and there were
significant differences in both survival and morphologic al-
terations compared with the control samples. Figure 3 shows
that 194 lM/L GPC with 3 h incubation before the radiation
delivery has significant protective effects, and identical effect
was detected with higher dose of GPC.
Histopathological and molecular evaluation. Microscopic
examination of radiation-induced cell damage of the different
organ systems revealed that the most severe deterioration
occurred at higher dose levels and there was an important
radioprotective effect of GPC. The histopathological as-
sessment showed changes in the skin, such as the disap-
pearance of mucous cells and development of subcutaneous
edema in the groups irradiated with 10 Gy at 6 hpf or 20 Gy at
24 hpf. In the observed individuals, the nervous tissue was
normal, but there were noticeable alterations in the cerato-
branchials. Figure 4A shows that there was decrease in goblet
cell numbers. In relation to the hepatopancreatic interstitial
edema, hydropic and simple pathologic signs of hepatocytes
were seen in individuals irradiated at 10 Gy dose level at 6 hpf
(Fig. 4B). Pycnotic changes in the nuclei of the hepatocytes
were also observed in the group irradiated with 20Gy at 24 hpf
(Fig. 4C).
The histological analysis revealed dose-dependent peri-
cardial deterioration, such as slight hydropericardium
(Fig. 4D) at the lowest dose level, and Figure 4E and F shows
that this abnormality is more pronounced at higher doses.
In the course of microscopic monitoring, any irradiation-
induced kidney damage was assessed, but disturbances were
determined in the yolk sac and ascites in the groups irradiated
with 10 or 20 Gy at 24 hpf. Furthermore, Figure 4 shows the
stock of vitellin is characterized by vacuoles for the group
exposed to 5 Gy at 6 hpf.
Finally, the histopathologic effects of radiation on the
developing gastrointestinal system were determined. In each
irradiated group, large amounts of mucous and catarrh were
present in the intestinal flux, and goblet cells were found in
the intestinal mucous membrane in the group irradiated with
20 Gy (Fig. 4C). In the 20 Gy irradiated group, cells with
irregular shapes and a larger hyperchromatic nuclei were
observed. These were characterized by pseudo-multilayer
epithelia and moderate disorganization of the columnar cells,
and the cytoplasm was wider in the intestinal lumen. The
severe alterations induced by IR in the developing gastroin-
testinal system were reduced and partially restored by GPC
pretreatment (Fig. 5).
It was found while investigating the early phase of pro-
inflammatory activation signal pathway that the IL-1b ex-
pression (Fig. 6) was reduced to the control level in the pre-
treated group, and thus, the induction of the NF-jB pathway
activation (Fig. 7) had been prevented.
These results show that IL-1b and NF-jB are activated in
response to injury at different times, when measured 1 and 2 h
after 10 Gy irradiation. This activation level was reduced
significantly in the GPC-treated groups.
Discussions
Our results are in line with other experiments,2 which
found that the age and radiation dose were proportional to
embryo malformation and lethality. McAleer et al.3 exposed
embryos at 1, 2, 4, 8, and 24 hpf to different doses of IR (2–20
Gy). They found that embryos were much more sensitive
(LD50 was 10 Gy for embryos irradiated at 4 hpf) in the
gastrula stage (1–2 hpf) and blastula stage (4 hpf) than in the
midblastula transition (8–24 hpf), and LD50 was 20 Gy for
embryos exposed to IR at 24 hpf. Similarly, we defined LD50
to be 15 Gy for embryos exposed to IR at 6 hpf embryos,
FIG. 3. The effects of ionizing radiation on zebrafish sur-
vival in the presence of GPC (l-alpha glycerylpho-
sphorylcholine). Zebrafish embryos at 24 hpf were mock
irradiated (Control), mock irradiated in the presence of GPC
(GPC), and irradiated with 20 Gy (RT) or 20 Gy in the
presence of GPC (GPC+RT). Survival and morphology were
evaluated at 24-h intervals up to 168 hpf. ***p< 0.001 rela-
tive to the control group. ###p< 0.001 relative to the irradiated
group.
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while half of the larvae irradiated with 20 Gy at 24 hpf were
viable at day 7. Daroczi et al.25 defined LD50 for embryos
irradiated at 24 hpf to be 20 Gy and, like this study, used this
dose level for the investigation of potential radiation modi-
fiers. These literature results are extremely consistent with
those presented in this article despite different radiation
sources being used for dose delivery. This strongly shows that
the zebrafish embryo model is well suited for radiation bi-
ology experiments. In addition to survival, our malformation
rate correlated to the dose up to the same degree as others had
previously established.
Phospholipids play a major role in rearrangement and re-
duction of toxicity against agents damaging the cell mem-
brane. However, little is known about the direct toxicity of
administrated phospholipids at high concentrations. To study
the GPC-related toxicity, we exposed embryos to increasing
concentrations of GPC at 24 hpf. Administration of GPC in
the range of 194 to 972 lM/L proved to be safe, because the
viability or morphology was not adversely affected. Higher
concentrations caused relevant distortions and there was almost
20% fatality at day 7 for the 1944 and 9720lM/L samples.
GPC works by decreasing the inflammatory proteins and
maintaining the membrane function. In our experiments, the
reduction of the edema and the preserved viability demon-
strated these protective effects and GPC provided protection
against radiation-induced overall lethality and damage to mul-
tiple organ systems of the developing zebrafish. The postradia-
tion surviving embryos were markedly malformed (shortened
and curved bodies, pericardial edema, and malformations of the
head and eye). These defects were also seen in embryos that
survived irradiation in the presence of GPC, but appeared less
severe and less pronounced.
FIG. 4. The different histological changes in irradiated zebrafish embryos. In (A; HE. 90 · . Scale bar 280lm), there is an
observed reduction in the number of goblet cells in the multilayer epithelium of ceratobranchials (cb). Yolk sac edema (yse).
Strength of vitellin was characterized by vacuoles. (B; HE. 180· . Scale bar 100 lm) shows oppressive hydropericardium
(hp), tissue edema (te), and hydropic and simple pathologic signs of hepatocytes. (C; HE. 200 · . Scale bar 40lm) shows
hepatocytes (hc) with pycnotic nuclei, mucous, and several goblet cells (gc) observed in the gastrointestinal mucous
membrane in the intestinal lumen. The degree of hydropericardial disturbances and changes in small intestine. (D; HE. 90 · .
Scale bar 200lm) has large amounts of mucous in the small intestinal lumen (msi). Stand by this disorder slight degree of
hydropericardium (hp) developed in (E; HE. 90 · . Scale bar 100 lm) shows severe, serous fibrinous hydropericardium (hp).
Reduction of goblet cells. (F; HE. 90 · . Scale bar 200lm) has severe hydropericardium (hp). Large amounts of mucus were
noticeable in the intestinal lumen. HE, hematoxylin and eosin. Color images available online at www.liebertpub.com/zeb
FIG. 5. The effects of GPC on radiation caused alterations
of the gastrointestinal system. Representative histological
sections of the intestine at 7 dpf; the arrows (/) indicate
the disorganization of the columnar cells in the intestinal
lumen. Embryos at 24 hpf were pretreated with 194lM/L
for 3 h before irradiation with 20 Gy. HE. 20 · . Scale bar
100 lm. dpf, days postfertilization. Color images available
online at www.liebertpub.com/zeb
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Radiation causes significant functional damage to the gas-
trointestinal system and will lead to death by starvation within
10 days after conception.26 In our observations, morphologic
alterations induced by IR in the developing gastrointestinal
system were reduced and partially restored by pretreatment
with GPC that may lead to the maintenance of nutritional
capability while decreasing the mortality rate.
There is cumulative evidence that the activation of ca-
nonical NF-jB pathway is a major contributor to radiation-
induced inflammatory changes in the normal tissues in the
developing vertebrate organism. The hypothesis of radio-
protection by inhibiting inflammatory modulators like NF-jB
was confirmed in the zebrafish model, in which the NF-jB
inhibitors ethyl-pyruvate and the synthetic triterpenoid CDDO-
TFEA (RTA401) were given in combination with radiation. In
other previous studies on zebrafish embryo radiation, investi-
gators observed protective effect of several NF-jB pathway
inhibitors.25 Therefore, the NF-jB and IL-1b gene expression
was studied, assuming that the observed protective effect of
GPC may follow from the inhibition of this pathway. IL-1b is
one of the essential pro-inflammatory cytokine of interleukin-1
family members27 and is rapidly induced after irradiation, and
this cytokine has also been implicated in edema shaping.28,29
Overexpression of IL-1b is the first sign of inflammatory ac-
tivation after IR, which induces the activation of the NF-jB
pathway.30
IL-1b and NF-jB overexpression was detected in the
embryos, 2 h after IR. The addition of GPC reduced the IL-1b
expression value down to the control level and prevented
activation of the NF-jB pathway. The role of the NF-jB
pathway activation in the early radiation response has already
been clearly established.31 The in vitro experiments were
mainly performed on tumor cell lines and there were relatively
few investigations assessing the effect of NF-jB inhibitors on
normal cells. The small animal studies with transgenic mouse
models failed due to the high mortality of the mouse embryos
with abnormal function of NF-jB pathway or were biased due
to compensatory molecular process activity. The zebrafish
embryos proved to be reliable model to study the effect of
NF-jB pathway modulation on radiation response.25,32 Our
observation of modulation of early pro-inflammatory activa-
tion by GPC at a nontoxic concentration could explain the
pronounced radioprotective effect of this agent.
Zebrafish experiments provide a good basis to study the
effects of IR on a large scale and proved to be a highly efficient
model for investigations on potential radiation modifying
agents. We have evaluated for the first time the protective
effects of GPC against IR exposure in the zebrafish embryo
model system. In this model, GPC exhibited promising pro-
tective effect against radiation-induced multiorgan morpho-
logical and histological impairment and overall lethality. Our
results suggest that the inhibition of early radiation-induced
activity of pro-inflammatory pathway activation could be a
potential mode of action of GPC.
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